(R)-Pazinaclone (BioDeep_00000172063)
human metabolite blood metabolite
代谢物信息卡片
化学式: C25H23ClN4O4 (478.1408)
中文名称: 帕秦克隆
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: C1CN(CCC12OCCO2)C(=O)CC3C4=CC=CC=C4C(=O)N3C5=NC6=C(C=C5)C=CC(=N6)Cl
InChI: InChI=1S/C25H23ClN4O4/c26-20-7-5-16-6-8-21(28-23(16)27-20)30-19(17-3-1-2-4-18(17)24(30)32)15-22(31)29-11-9-25(10-12-29)33-13-14-34-25/h1-8,19H,9-15H2
描述信息
C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
同义名列表
数据库引用编号
6 个数据库交叉引用编号
- PubChem: 59743
- HMDB: HMDB0243694
- chemspider: 53893
- CAS: 103255-66-9
- CAS: 147724-27-4
- CAS: 147724-30-9
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
1 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:
- PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。
亚细胞结构定位 | 关联基因列表 |
---|
文献列表
- T Kondo, K Yoshida, S Tanayama. Absorption of the anxiolytic pazinaclone in animals as a criterion for species selection for toxicity studies.
Arzneimittel-Forschung.
1996 Sep; 46(9):839-43. doi:
NULL
. [PMID: 8876929] - T Kondo, K Yoshida, Y Yoshimura, S Tanayama. Enantioselective pharmacokinetics in animals of pazinaclone, a new isoindoline anxiolytic, and its active metabolite.
Biopharmaceutics & drug disposition.
1995 Dec; 16(9):755-73. doi:
10.1002/bdd.2510160906
. [PMID: 8580400] - M Suzuki, M Uchiumi, M Murasaki. A comparative study of the psychological effects of DN-2327, a partial benzodiazepine agonist, and alprazolam.
Psychopharmacology.
1995 Oct; 121(4):442-50. doi:
10.1007/bf02246492
. [PMID: 8619007] - T Kondo, K Hamasaki, M Yamaguchi, I Aoki, K Yoshida, Y Yoshimura, S Tanayama. Enantioselective determination of pazinaclone, a new isoindoline anxiolytic, and its active metabolite in rat plasma by high-performance liquid chromatography.
Journal of chromatography. B, Biomedical applications.
1995 Apr; 666(2):291-7. doi:
10.1016/0378-4347(94)00574-o
. [PMID: 7633605] - T Kondo, Y Kurata, K Yoshida, Y Yoshimura. Disposition of DN-2327, a new anxiolytic, in rats, dogs, and monkeys.
Biological & pharmaceutical bulletin.
1995 Feb; 18(2):330-6. doi:
10.1248/bpb.18.330
. [PMID: 7742808] - T Kondo, K Yoshida, S Tanayama. Analysis of dog and rat plasma for metabolites of a new isoindoline anxiolytic, DN-2327, by liquid chromatography/thermospray mass spectrometry and tandem mass spectrometry.
Biological mass spectrometry.
1994 Jun; 23(6):323-9. doi:
10.1002/bms.1200230605
. [PMID: 7913625] - Z Hussein, D J Mulford, B A Bopp, G R Granneman. Stereoselective pharmacokinetics of pazinaclone, a new non-benzodiazepine anxiolytic, and its active metabolite in healthy subjects.
British journal of clinical pharmacology.
1993 Oct; 36(4):357-61. doi:
10.1111/j.1365-2125.1993.tb00376.x
. [PMID: 12959315] - Z Hussein, D J Mulford, B A Bopp, G R Granneman. Differences in the stereoselective pharmacokinetics of pazinaclone (DN-2327), a new anxiolytic, and its active metabolite after intravenous and oral single doses to dogs.
Drug metabolism and disposition: the biological fate of chemicals.
1993 Sep; 21(5):805-10. doi:
NULL
. [PMID: 7902240] - Z Hussein, S Y Chu, G R Granneman. High-performance liquid chromatographic method for determination of DN-2327, a novel non-benzodiazepine anxiolytic, and/or its active metabolite in human plasma and urine.
Journal of chromatography.
1993 Mar; 613(1):105-12. doi:
10.1016/0378-4347(93)80202-f
. [PMID: 8096213] - Z Hussein, S Y Chu, G R Granneman. Enantioselective determination of DN-2327, a novel non-benzodiazepine anxiolytic, and/or its active metabolite in human plasma and urine using high-performance liquid chromatography.
Journal of chromatography.
1993 Mar; 613(1):113-20. doi:
10.1016/0378-4347(93)80203-g
. [PMID: 8096214]